[Results of treatment with spasmolytic spasmocompren in diseases of the stomach, intestine and gallbladder].
D005705:Gallbladder Diseases; D005767:Gastrointestinal Diseases / Q000628:therapy*; D007422:Intestines; D010276:Parasympatholytics; D010634:Phenobarbital / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use*; D013270:Stomach
D010276:Parasympatholytics; D012601:Scopolamine; D010634:Phenobarbital
GALLBLADDER/diseases; GASTROINTESTINAL DISEASES/therapy; PHENOBARBITAL/therapeutic use; SCOPOLAMINE/therapeutic use
Uber Behandlungsergebnisse mit dem Spasmolytikum Spasmocompren bei Erkrankungen des Magens, Darmes und der Gallenblase.